Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: A systematic review

European Respiratory Journal

Volumn 44, Issue 2, 2014, Pages 382-393

  Brodt, Alessandra Monteiro ^a   Stovold, Elizabeth ^b   Zhang, Linjie ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; PLACEBO; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; BRONCHIECTASIS; BRONCHOSPASM; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; LUNG FUNCTION TEST; META ANALYSIS; MICROBIOLOGY; NON CYSTIC FIBROSIS BRONCHIECTASIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SCORING SYSTEM; SPUTUM EXAMINATION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; BRONCHUS; CYSTIC FIBROSIS; INHALATIONAL DRUG ADMINISTRATION; PATIENT SAFETY; PSEUDOMONAS INFECTIONS; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ANTI-BACTERIAL AGENTS; BRONCHI; BRONCHIECTASIS; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; HUMANS; PATIENT SAFETY; PSEUDOMONAS INFECTIONS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84905644717     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00018414     Document Type: Article

References (37)

1. Seitz AE, Olivier KN, Adjemian J, et al. Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000 to 2007. Chest 2012; 142: 432-439.
2. Wang Z. Bronchiectasis: still a problem. Chin Med J 2014; 127: 157-172.
3. Seitz AE, Olivier KN, Steiner CA, et al. Trends and burden of bronchiectasis-associated hospitalisations in the United States, 1993-2006. Chest 2010; 138: 944-949.
4. Barker AF. Bronchiectasis. N Engl J Med 2002; 346: 1383-1393. (Pubitemid 34754612)
5. Cole PJ. Inflammation: a two-edged sword - the model of bronchiectasis. Eur J Respir Dis Suppl 1986; 147: 6-15. (Pubitemid 16017382)
6. Chalmers JD, Smith MP, McHugh BJ, et al. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2012; 186: 657-665.
7. Evans DJ, Bara AI, Greenstone M. Prolonged antibiotics for purulent bronchiectasis in children and adults. Cochrane Database Syst Rev 2007; 2: CD001392.
8. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
9. Barker AF, Couch L, Fiel SB, et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 2000; 162: 481-485. (Pubitemid 30647187)
10. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. Oxford, The Cochrane Collaboration, 2011.
11. Wilson R, Welte T, Polverino E, et al. Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study. Eur Respir J 2013; 41: 1107-1115.
12. Antoniu S, Azoicai D. Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a Phase II randomized study. Expert Opin Investig Drugs 2013; 22: 671-673.
13. Bilton D, Henig N, Morrissey B, et al. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Chest 2006; 130: 1503-1510. (Pubitemid 44786746)
14. Dhar R, Anwar GA, Bourke SC, et al. Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa. Thorax 2010; 65: 553.
15. Crowther Labiris NR, Holbrook AM, Chrystyn H, et al. Dry powder versus intravenous and nebulised gentamicin in cystic fibrosis and bronchiectasis. A pilot study. Am J Respir Crit Care Med 1999; 160: 1711-1716.
16. de Lima LS, Bogossian M. Avaliacao da resposta clinica ao uso de antibioticos por via oral e via inalatoria em pacientes portadores de bronquiectasias [Clinical response to inhalation and oral antibiotics in patients with bronchiectasis]. Rev Assoc Med Bras 1999; 45: 229-236.
17. Scheinberg P, Shore E. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest 2005; 127: 1420-1426. (Pubitemid 46224309)
18. Steinfort DP, Steinfort C. Effect of long-term nebulised colistin on lung function and quality of life in patients with chronic bronchial sepsis. Intern Med J 2007; 37: 495-498. (Pubitemid 46855088)
19. Lin HC, Cheng HF, Wang CH, et al. Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis. Am J Respir Crit Care Med 1977; 155: 2024-2029.
20. Couch LA. Treatment with tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa. Chest 2001; 120: Suppl., 114S-117S. (Pubitemid 32881573)
21. Gilead Sciences. Safety and effectiveness of AZLI (an inhaled antibiotic) in adults with non-cystic fibrosis bronchiectasis (AIR-BX1). http://clinicaltrials.gov/ct2/show/NCT01313624 Date last updated: March 7, 2014. Date last accessed: March 10, 2014.
22. Gilead Sciences. Safety and effectiveness of AZLI (an inhaled antibiotic) in adults with non-cystic fibrosis bronchiectasis (AIR-BX2). Date last updated: March 7, 2014. Date last accessed: March 10, 2014.
23. Barker A, O'Donnell A, Thompson PJ, et al. Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB). Eur Respir J 2013; 42: Suppl. 57, 877s.
24. Aradigm Corp. Safety and efficacy study of ciprofloxacin for inhalation in patients with non-cystic fibrosis bronchiectasis "ORBIT-1". http://clinicaltrials.gov/show/NCT00889967 Date last updated: August 27, 2012. Date last accessed: March 10, 2014.
25. Aradigm Reports Successful ORBIT-1 Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin. Available from: www.drugs.com/clinical-trials/aradigm- reports-successful-orbit-1-bronchiectasis-study-inhaled-liposomal-ciprofloxacin- 11989.html Date last updated: June 2011. Date last accessed: March 10, 2014.
26. Insmed. A study to determine the safety and tolerability of ArikaceTM versus placebo in patients who have bronchiectasis. http://clinicaltrials.gov/ show/NCT00775138 Date last updated: May 31, 2012. Date last accessed: March 10, 2014.
27. Insmed, Inc. TR02-107 trial report. Available from: www.insmed.com/pdf/ Pub9%209-13-09.pdf Date last updated: September 13, 2009. Date last accessed: March 10, 2014.
28. Tabernero E, Gil P, Alkiza R, et al. Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa (PA) bronchial infection. Chest 2014; 145: 431A.
29. Drobnic ME, Suñé P, Montoro JB, et al. Inhaled tobramycin in non-fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann Pharmacother 2005; 39: 39-44.
30. Haworth CS, Foweraker JE, Wilkinson P, et al. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2014; 189: 975-982.
31. Murray MP, Govan JR, Doherty CJ, et al. A randomised controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2011; 183: 491-499.
32. Orriols R, Roig J, Ferrer J, et al. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir Med 1999; 93: 476-480. (Pubitemid 29364062)
33. Serisier DJ, Bilton D, De Soyza A, et al. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial. Thorax 2013; 68: 812-817.
34. Geller DE. Aerosol antibiotics in cystic fibrosis. Respir Care 2009; 54: 658-669.
35. Ryan G, Singh M, Dwan K. Inhaled antibiotics for long-term therapy in cystic fibrosis. Cochrane Database Syst Rev 2011; 3: CD001021.
36. Pasteur MC, Bilton D, Hill AT, et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65: i1-i58.
37. Hopewell S, Loudon K, Clarke MJ, et al. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev 2009; 1: MR000006.